Skip to main content

One-Sided Versus Two-Sided Testing

  • Chapter
Statistical Reasoning in Medicine
  • 1369 Accesses

8.11 Conclusions

I believe one-sided (benefit only) testing reflects a mindset of physicians and healthcare researchers who believe their intervention can produce no harm, a philosophy that has been shown repeatedly to be faulty, and dangerous to patients and their families. Investigators who agree to the one-sided (benefit only) approach to significance testing in a clinical experiment have closed parts of their minds to the possibility of harm entering into an avoidable flirtation with danger. In this sense, the one-sided test is not the disease, it is only a symptom.

We as physicians and healthcare workers feel strongly about the treatment programs we advocate. This is required in our profession. However, these strong feelings often betray us since our day-to-day experience does not provide an objective view of the treatments. We need every tool we can find to help us gain that objective vantage point. The use of a two-sided significance test is of utmost importance. A forceful, intelligent argument for ethics will argue not only for a two-sided test, but asymmetrical allocation of alpha. Prospective identification of alpha is again critical here, and community protection predominates all other concerns. A sensitive, perceptive, ethical approach to alpha allocation for sidedness can complicate experimental design, but complexity in the name of ethics is no vice.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Knottnerus JA, Bouter LM (2001) Commentary: The ethics of sample size: two-sided testing and one-sided thinking. Journal of Clinical Epidemiology 54:109–110.

    Article  Google Scholar 

  2. Leyman EL (1986) Testing Statistical Hypotheses. New York. John Wiley and Sons.

    Google Scholar 

  3. Moore T (1995) Deadly Medicine. New York Simon and Schuster.

    Google Scholar 

  4. The CAST Investigators (1989) Preliminary Report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. New England Journal of Medicine. 3212:406–412.

    Google Scholar 

  5. The Lipid Research Clinic Investigators (1979) The Lipid Research Clinics Program: The Coronary Primary Prevention Trial; Design and implementation. Journal of Chronic Diseases 32:609–631.

    Article  Google Scholar 

  6. The Lipid Research Clinic Investigators. (1984) The Lipid Research Clinics Coronary Primary Prevention trial results. Journal of the Amerian Medical Association 251: 351–74.

    Article  Google Scholar 

  7. Moyé LA, Tita, A (2002) Defending the Rationale for the Two-Tailed Test in Clinical Research. Circulation 105: 3062–3065.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Moyé, L.A. (2006). One-Sided Versus Two-Sided Testing. In: Statistical Reasoning in Medicine. Springer, New York, NY. https://doi.org/10.1007/978-0-387-46212-7_9

Download citation

Publish with us

Policies and ethics